Crohn's Disease (CD) is a chronic inflammatory disorder that potentially involves the entire gastrointestinal tract. Perianal fistulizing CD (pCD) is a serious and frequent complication associated with significant morbidities and a heavy negative impact on quality of life. The aim of CD treatment is to induce and maintain disease remission and to promote mucosal repair. Unfortunately, even the best therapeutic regimens in pCD do not have long-term efficacy and cause a significant number of side effects. Therefore, it is mandatory to study new therapeutical options such as the use of mesenchymal stromal cells (MSCs). These cells promote tissue repair via the induction of immunomodulation. The present review aims to analyze the existing updated scientific literature on MSCs adoption in the treatment of pCD to evaluate its efficacy and safety and to compare the use of bone marrow and adipose tissue derived MSCs, type of administration, and dose required for recovery.

Mesenchymal Stromal Cell Therapy in the Management of Perianal Fistulas in Crohn’s Disease. An Up-To-Date Review / Gallo, Gaetano; Tiesi, Vincenzo; Fulginiti, Serena; De Paola, Gilda; Vescio, Giuseppina; Sammarco, Giuseppe. - In: MEDICINA. - ISSN 1010-660X. - 56:11(2020). [10.3390/medicina56110563]

Mesenchymal Stromal Cell Therapy in the Management of Perianal Fistulas in Crohn’s Disease. An Up-To-Date Review

Gaetano Gallo
;
2020

Abstract

Crohn's Disease (CD) is a chronic inflammatory disorder that potentially involves the entire gastrointestinal tract. Perianal fistulizing CD (pCD) is a serious and frequent complication associated with significant morbidities and a heavy negative impact on quality of life. The aim of CD treatment is to induce and maintain disease remission and to promote mucosal repair. Unfortunately, even the best therapeutic regimens in pCD do not have long-term efficacy and cause a significant number of side effects. Therefore, it is mandatory to study new therapeutical options such as the use of mesenchymal stromal cells (MSCs). These cells promote tissue repair via the induction of immunomodulation. The present review aims to analyze the existing updated scientific literature on MSCs adoption in the treatment of pCD to evaluate its efficacy and safety and to compare the use of bone marrow and adipose tissue derived MSCs, type of administration, and dose required for recovery.
2020
mesenchymal stromal cells; stem cells; Crohn disease; perianal fistula; fistulizing CD; surgical treatment
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Mesenchymal Stromal Cell Therapy in the Management of Perianal Fistulas in Crohn’s Disease. An Up-To-Date Review / Gallo, Gaetano; Tiesi, Vincenzo; Fulginiti, Serena; De Paola, Gilda; Vescio, Giuseppina; Sammarco, Giuseppe. - In: MEDICINA. - ISSN 1010-660X. - 56:11(2020). [10.3390/medicina56110563]
File allegati a questo prodotto
File Dimensione Formato  
Gallo_Mesenchymal-Stromal_2020.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 676.67 kB
Formato Adobe PDF
676.67 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1661751
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 9
social impact